Home › Market › 2026-09-21

US Stock Analysis and Analyst Forecasts — September 21, 2026

Meta's Muse AI agent drove a tech-led Monday — Meta closed up 11.34% after Wells Fargo lifted its target to $796, and Arm, Intel and AMD rallied 10% to 17% on the CPU-demand read-through — while oil below $100 eased rate-hike odds and Novo Nordisk fell 7.92% despite a winning CagriSema trial.

None of the following is our own view on any stock — it is a same-day record of market action, analyst-firm calls and company news across the tracked universe on Monday, September 21, 2026.

U.S. stocks opened the week with a broad, tech-led rally. The S&P 500 closed at 7,764.76, up 1.49%, the Nasdaq 100 at 30,482.35, up 2.83%, and the Dow Jones Industrial Average at 52,049.54, up 0.71%. Oil did much of the macro work: Brent fell more than 4% intraday and slipped below $100, and U.S. crude settled around $96, down about 3.9%, after President Trump said he would "probably" meet Iran's President Masoud Pezeshkian on the sidelines of the United Nations General Assembly this week — a meeting that revived hopes of progress toward ending the war, even though shipping through the Strait of Hormuz remains badly constrained, with 17 commodity vessels crossing over the weekend against 37 the weekend before. Cheaper oil pulled rate-hike expectations lower: futures-implied odds of a quarter-point increase at the Federal Reserve's October 28 meeting eased to about 53% from about 58% on Friday. Gold slipped 0.75% and bitcoin gained roughly 6.6% to about 86,500. Chevron (CVX), the only energy name in the Dow, fell 2.73% to $203.78.

The day's single biggest story was Meta Platforms (META), which closed at $741.25, up 11.34%, on enthusiasm for Muse, the personal AI agent it launched recently. Muse is built to act rather than just answer — sending emails, filling in forms and arranging travel through other apps — and it has been the most-downloaded free iPhone app in the U.S. over the past three days, according to app-tracking data. Ahead of Meta Connect on September 23 and 24, Wells Fargo's Ken Gawrelski raised his price target to $796 from $640 and kept an Overweight rating, saying he expects product demos and new Muse functionality at the event, likely usage commentary rather than daily-user figures this early, and possibly news of a new large model code-named Watermelon. The Street is almost uniformly positive — Strong Buy on 38 Buys, six Holds and no Sells — but after Monday's jump the $763.67 average target sits only about 3% above the close.

Muse also lifted the processor makers, on the reasoning that an AI agent working on a user's behalf runs on a virtual computer that needs conventional CPUs as well as accelerators. Arm Holdings (ARM) closed up 17.16% at $322.90, Intel (INTC) up 12.14% at $121.78, AMD (AMD) up 9.95% at $615.52 and Qualcomm (QCOM) up 9.29% at $194.23. Intel added its own tailwinds: reports that CPU demand is running at roughly twice what it can supply, and that it is in talks with Taiwan's AUO over Micro LED technology for advanced chip packaging. Piper Sandler's David O'Connor split the two big CPU names. On AMD he is Overweight, forecasting about 1.5 million Instinct accelerator shipments in 2027, server-CPU unit share rising to 49% by 2030 from the mid-30s today, and revenue compounding at about 50% a year through 2030 with earnings per share approaching $53 — but Monday's close already sits above his $600 target. On Intel he praised the rebuild of culture, products and customer trust, noted that eight large tech companies are evaluating its 14A process, and still kept a Neutral rating and a $110 target, about 10% below the close, estimating the share price already assumes roughly 15% foundry share gains. The wider Street is similarly cautious on Intel: Hold on seven Buys, 23 Holds and two Sells, with a $117.56 average target that is about 3.5% below Monday's close.

The rest of semiconductors followed. Nvidia (NVDA) rose 2.30% to $227.38, TSMC (TSM) 2.42% to $445.18, Broadcom (AVGO) 1.41% to $362.66 and Micron (MU) 2.77% to $1,043.96 ahead of its September 30 report. Marvell Technology, outside our tracked universe, gained 5.38% to $257.38 after Morgan Stanley's Joseph Moore raised his target to $268 from $246 while keeping a Hold on valuation grounds; he expects the October 6 investor day to set a fiscal-2030 revenue goal above $40 billion, with the custom-chip partnership with Google as the largest driver. Among the other megacaps, Tesla (TSLA) rose 3.00%, Amazon (AMZN) 1.87%, Alphabet (GOOGL) 1.55% and Microsoft (MSFT) 1.59%, and Caterpillar (CAT) added 0.95% on continued data-center demand.

Healthcare produced the day's sharpest loser. Novo Nordisk (NVO) fell 7.92% to $39.81 after its capital markets day in London, where chief executive Mike Doustdar set a target of more than DKK 150 billion (about $23 billion) of sales from drugs now in development and said the company plans to launch more than five multi-blockbusters by 2030. Investors were not reassured, even though Novo also reported that its next-generation drug CagriSema cut body weight by 12.4% at week 60 in a head-to-head trial in type 2 diabetes, against 9.1% for Eli Lilly's tirzepatide — a reversal of an earlier trial in February that failed to show superiority. The overhang is market share: earlier this month Morgan Stanley's Thibault Boutherin downgraded the stock to Sell, citing a survey pointing to share losses to Lilly over the next 18 months and U.S. semaglutide patent expiry in 2032. Analysts hold a Hold consensus on five Holds and one Sell, with a $44 average target about 10% above the close. Eli Lilly (LLY) rose 1.02% to $1,164.65 after chief executive David Ricks said one in three new weight-loss-pill patients is now starting on Foundayo, its oral drug approved in April, as the company broke ground on a $6.5 billion plant in Houston; Lilly carries a Strong Buy consensus on 18 Buys and two Holds with a $1,375.78 average target. Moderna (MRNA) jumped 12.27% to $172.94; we could not verify a single company-specific catalyst for the move before publication.

Looking ahead, the week's scheduled risks are mostly macro and political: the Trump–Xi summit at the White House runs from September 23 to 25, with a trade-truce extension, AI and national security on the agenda, and Meta Connect falls on September 23 and 24. Inside the tracked universe, Costco (COST, up 0.35% to $898.48) reports on September 24 and Micron on September 30; AutoZone and KB Home, both outside our coverage, report on September 22. As always: a price target is one firm's estimate and not a forecast of what a stock will do, a double-digit one-day move on a product launch can reverse just as quickly, and none of this is a recommendation to buy or sell anything.

Tickers in this brief

Published 2026-09-21. Market commentary, not investment advice. Prices are delayed end-of-day data.